![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 51, 39041-39050, December 22, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
1
2
From the
Departments of
Biological Science and
Pathology and the ||Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260 and the ¶Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390
Mucolipidosis type IV is a genetic lysosomal storage disease associated with degenerative processes in the brain, eye, and other tissues. Mucolipidosis type IV results from mutations in the gene MCOLN1, which codes for the TRP family ion channel, mucolipin 1. The connection between lysosomal dysfunction and degenerative processes in mucolipidosis type IV is unclear. Here we report that mucolipidosis type IV and several unrelated lysosomal storage diseases are associated with significant mitochondrial fragmentation and decreased mitochondrial Ca2+ buffering efficiency. The mitochondrial alterations observed in these lysosomal storage diseases are reproduced in control cells by treatment with lysosomal inhibitors and with the autophagy inhibitor 3-methyladenine. This suggests that inefficient autophagolysosomal recycling of mitochondria generates fragmented, effete mitochondria in mucolipidosis. Mitochondria accumulate that cannot properly buffer calcium fluxes in the cell. A decrease in mitochondrial Ca2+ buffering capacity in cells affected by these lysosomal storage diseases is associated with increased sensitivity to apoptosis induced by Ca2+-mobilizing agonists and executed via a caspase-8-dependent pathway. Deficient Ca2+ homeostasis may represent a common mechanism of degenerative cell death in several lysosomal storage diseases.
Received for publication, August 21, 2006 , and in revised form, October 6, 2006.
* This work was supported by the Pittsburgh Life Science Greenhouse start-up fund, a Winters Foundation grant, and the University of Pittsburgh Small Grant Development Fund and by a Mucolipidosis IV Foundation grant (to K. K.), National Institutes of Health Grant NS40817, and a pilot grant from the University of Pittsburgh Center for the Environmental Basis of Human Disease (to C. T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.
1 These authors contributed equally to this work.
2 To whom correspondence should be addressed: Dept. of Biological Sciences, University of Pittsburgh, 4249 Fifth Ave., Pittsburgh, PA 15260. Tel.: 412-624-4317; E-mail: Kiselyov{at}pitt.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. T. Miedel, Y. Rbaibi, C. J. Guerriero, G. Colletti, K. M. Weixel, O. A. Weisz, and K. Kiselyov Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis J. Exp. Med., June 9, 2008; 205(6): 1477 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Chu Eaten Alive: Autophagy and Neuronal Cell Death after Hypoxia-Ischemia Am. J. Pathol., February 1, 2008; 172(2): 284 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Settembre, A. Fraldi, L. Jahreiss, C. Spampanato, C. Venturi, D. Medina, R. de Pablo, C. Tacchetti, D. C. Rubinsztein, and A. Ballabio A block of autophagy in lysosomal storage disorders Hum. Mol. Genet., January 1, 2008; 17(1): 119 - 129. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |